The in vitro antibacterial activity of LY127935 (6059S), a novel 1-oxa-beta-lactam antibiotic.
D001439:Bacteroides / Q000187:drug effects; D002511:Cephalosporins / Q000627:therapeutic use*; D002513:Cephamycins / Q000627:therapeutic use*; D004755:Enterobacteriaceae / Q000187:drug effects*; D006088:Gram-Negative Aerobic Bacteria / Q000187:drug effects; D006193:Haemophilus influenzae / Q000187:drug effects; D008826:Microbial Sensitivity Tests; D009070:Moxalactam; D013211:Staphylococcus aureus / Q000187:drug effects; D013289:Streptococcaceae / Q000187:drug effects; D001618:beta-Lactamases / Q000494:pharmacology*
D002511:Cephalosporins; D002513:Cephamycins; D001618:beta-Lactamases; D009070:Moxalactam